Skip to main
TFX

Teleflex (TFX) Stock Forecast & Price Target

Teleflex (TFX) Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 11%
Buy 44%
Hold 44%
Sell 0%
Strong Sell 0%

Bulls say

Teleflex is a leader in the medical technology industry with a strong focus on enhancing clinical benefits and reducing procedural costs. Its diverse range of products and global presence make it well-positioned for continued growth. Additionally, the company's unique and differentiated resorbable metallic scaffold, Freesolve, could potentially drive significant earnings growth in the future. While there are some risks to consider, such as slower than expected growth or delays with the Biotronik integration, the company's strong financial performance, progress in capital deployment, and potential for future acquisitions suggest a favorable outlook.

Bears say

Teleflex is facing challenges with the integration of Biotronik and its capital deployment strategy may temporarily boost earnings, but ultimately the road to significant earnings growth will be longer than expected. With a higher forecast and P/E multiple in comparison to its peers, Teleflex's current stock price is not justified, even considering potential interest from private equity firms for a takeout. The company's operating margin is expected to normalize and see significant EPS growth in 2027, but that is still a few years away.

Teleflex (TFX) has been analyzed by 9 analysts, with a consensus rating of Buy. 11% of analysts recommend a Strong Buy, 44% recommend Buy, 44% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Teleflex and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Teleflex (TFX) Forecast

Analysts have given Teleflex (TFX) a Buy based on their latest research and market trends.

According to 9 analysts, Teleflex (TFX) has a Buy consensus rating as of Sep 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $152.44, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $152.44, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Teleflex (TFX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.